driven by the PitchBook Platform
Developer of biopharmaceutical products. The company is focused on development of the drug Adrecizumab, as a treatment for sepsis.
You’re viewing a free company profile from the PitchBook Platform. To explore Adrenomed’s full profile, request a free trial.
© 2017 PitchBook Data. All rights reserved. PitchBook is a financial technology company that provides data on the capital markets.